Clinical Trial Update: Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Tc-99m tilmanocept imaging with IHC analysis of CD206 in synovial tissue from rheumatoid arthritis patients; the study was terminated an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2025-01-08